Lappe Mark Insider Trading Activity

Average Profitability

<0.0001%

Insider Buys Quantity

Insider Buys Sum

$14.43M

Insider Sells Quantity

Insider Sells Sum

$2.82M

Insider Activity of Lappe Mark

According to the SEC Form 4 filings, Lappe Mark, being in a position of

Chief Executive Officer at Inhibrx Biosciences Inc.,
оver the last 12 months, has bought 20040 shares for $1.85M, and sold 0 shares,
over all time since 2022-10-17, has bought 104040 shares for $3.15M, and sold 104060 shares for $2.82M.

Biography of Lappe Mark

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks


Buys	$1,847,761	3	100
Sells	$0	0	0

Comparison of Insiders on Amount of Buys and Sells

Sector

Industry

Transaction Type

Transaction Date

From

Total Value


2026-10-14	Purchase	Inhibrx Biosciences Inc. INBX	Chief Executive Officer	10,040 0.0677%	$84.56	$848,977	+5.34%
2026-09-28	Purchase	Inhibrx Biosciences Inc. INBX	Chief Executive Officer	4,500 0.0285%	$100.76	$453,426	-8.5%
2026-09-25	Purchase	Inhibrx Biosciences Inc. INBX	Chief Executive Officer	5,500 0.0349%	$99.16	$545,357	-6.27%
2024-09-16	Purchase	Inhibrx, Inc. INBX	Chief Executive Officer	13,037 0.0885%	$17.13	$223,324	-15.81%
2024-09-12	Purchase	Inhibrx, Inc. INBX	Chief Executive Officer	26,963 0.1859%	$15.05	$405,793	-2.69%
2024-09-10	Purchase	Inhibrx, Inc. INBX	Chief Executive Officer	8,500 0.0588%	$15.19	$129,115	-3.33%
2024-09-09	Purchase	Inhibrx, Inc. INBX	Chief Executive Officer	9,500 0.0657%	$15.21	$144,495	-3.45%
2024-09-06	Purchase	Inhibrx, Inc. INBX	Chief Executive Officer	26,000 0.1824%	$15.29	$397,540	-2.59%
2023-02-28	Sale	Inhibrx, Inc. INBX	Chief Executive Officer	60 0.0002%	$25.02	$1,501	-5.41%
2023-01-24	Sale	Inhibrx, Inc. INBX	Chief Executive Officer	4,335 0.0103%	$25.72	$111,478	-15.76%
2023-01-23	Sale	Inhibrx, Inc. INBX	Chief Executive Officer	21,665 0.0538%	$25.36	$549,364	-10.6%
2022-12-19	Sale	Inhibrx, Inc. INBX	Chief Executive Officer	26,000 0.06%	$25.56	$664,443	-11.21%
2022-11-17	Sale	Inhibrx, Inc. INBX	Chief Executive Officer	26,000 0.0574%	$27.88	$724,910	-20.89%
2022-10-17	Sale	Inhibrx, Inc. INBX	Chief Executive Officer	26,000 0.0593%	$29.59	$769,443	-20.95%
2008-10-31	Purchase	Royalty Pharma plc RPRX		11,300 0.0007%	$7.76	$87,688
2008-10-29	Purchase	Royalty Pharma plc RPRX		24,400 0.0014%	$6.97	$170,068
2008-10-28	Purchase	Royalty Pharma plc RPRX		9,892 0.0006%	$6.87	$67,958
2008-10-27	Purchase	Royalty Pharma plc RPRX		14,825 0.0009%	$6.85	$101,551
2008-10-24	Purchase	Royalty Pharma plc RPRX		30,000 0.0017%	$6.89	$206,700
2008-10-23	Purchase	Royalty Pharma plc RPRX		17,309 0.0009%	$6.32	$109,393

Total: 24

Company

About Prismo.pro Ideas Articles Privacy Policy Terms of Service Contact Us

Screener Ideas

Dividend Stocks Blue Chip Stocks Defensive Stocks Growth Stocks Value Stocks Cyclical Stocks Penny Stocks

Stock Tools

Insiders Screener Stocks Screener Top Stocks Stock News Insider Ratio List of All Stocks

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.